FDA OMH has a new name!

FDA OMH has a new name: FDA Office of Minority Health and Health Equity (OMHHE)

Effective March 31, 2019, FDA will begin operational implementation of an agency reorganization. FDA's reorganization reflects the agency's commitment to modernizing its structure to advance its mission to protect and promote public health, and to meet the challenges of rapid innovation across the industries regulated by FDA. The FDA's reorganization will realign several entities across the agency to promote strategic priorities, and will elevate the role of the centers, offices, and field forces. From this reorganization, the Office of Minority Health's name was changed to the Office of Minority Health and Health Equity (OMHHE). This change better captures the breadth of the office's portfolio and will allow the office to continue to address the needs of racial and ethnic minority populations and underserved communities. The core functions of our office and the reporting structure remain the same. Please visit our website to view the new organization chart.